4006-776-356 出国就医服务电话

免费获得国外相关药品,最快 1 个工作日回馈药物信息

出境医 / 临床实验 / Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis (BRONCHIOLITIS)

Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis (BRONCHIOLITIS)

Study Description
Brief Summary:
Bronchiolitis is the leading cause of pediatric intensive care unit admission in infants. Seizures during bronchiolitis may be a neurological complication of respiratory viruses but also of the treatments. The investigating team's hypothesis is that the incidence of seizures is not so so uncommon in infants hospitalized in the pediatric intensive care unit for severe bronchiolitis.

Condition or disease Intervention/treatment
Bronchiolitis Seizures Hyponatremia Other: Incidence, management and risk factors of seizure

Study Design
Layout table for study information
Study Type : Observational
Actual Enrollment : 805 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis : Description and Risk Factors
Actual Study Start Date : April 1, 2018
Actual Primary Completion Date : August 1, 2018
Actual Study Completion Date : May 1, 2019
Arms and Interventions
Group/Cohort Intervention/treatment
Children admitted in the PICU for severe bronchiolitis
Children admitted in the Pediatric Intensive Care Unit (PICU) for severe bronchiolitis between January 1st, 2010 and April 30th, 2018
Other: Incidence, management and risk factors of seizure
Incidence of seizure, management (treatment, paraclinical examinations) and risk factors of seizure in children admitted for severe bronchiolitis

Outcome Measures
Primary Outcome Measures :
  1. : Incidence of seizure during bronchiolitis (before or during hospitalization in the pediatric intensive care unit) [ Time Frame: Day 1 ]
    Clinical or infra-clinical (diagnosed on Electroencephalography, EEG) seizure, simple or status epilepticus


Eligibility Criteria
Layout table for eligibility information
Ages Eligible for Study:   up to 90 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
All children hospitalized in the pediatric intensive care unit
Criteria

Inclusion Criteria:

  • age < 90 days
  • hospitalization from January 1st, 2010 to April 30th, 2018 in the Pediatric Intensive Care Unit (PICU) of pediatric hospital in Lyon
  • with bronchiolitis (clinical diagnosis according to American Academy of Pediatrics)

Exclusion Criteria:

  • neurological history that may explain the occurrence of seizures
  • significant congenital heart disease
Contacts and Locations

Locations
Layout table for location information
France
Hôpital Femme Mère Enfant
Bron, France, 69677
Sponsors and Collaborators
Hospices Civils de Lyon
Investigators
Layout table for investigator information
Principal Investigator: Florent BAUDIN, MD Hospices Civils de Lyon
Tracking Information
First Submitted Date July 15, 2019
First Posted Date July 17, 2019
Last Update Posted Date July 17, 2019
Actual Study Start Date April 1, 2018
Actual Primary Completion Date August 1, 2018   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 15, 2019)
: Incidence of seizure during bronchiolitis (before or during hospitalization in the pediatric intensive care unit) [ Time Frame: Day 1 ]
Clinical or infra-clinical (diagnosed on Electroencephalography, EEG) seizure, simple or status epilepticus
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis
Official Title Seizures in Infants Hospitalized in Pediatric Intensive Care Unit for Bronchiolitis : Description and Risk Factors
Brief Summary Bronchiolitis is the leading cause of pediatric intensive care unit admission in infants. Seizures during bronchiolitis may be a neurological complication of respiratory viruses but also of the treatments. The investigating team's hypothesis is that the incidence of seizures is not so so uncommon in infants hospitalized in the pediatric intensive care unit for severe bronchiolitis.
Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Cohort
Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All children hospitalized in the pediatric intensive care unit
Condition
  • Bronchiolitis
  • Seizures
  • Hyponatremia
Intervention Other: Incidence, management and risk factors of seizure
Incidence of seizure, management (treatment, paraclinical examinations) and risk factors of seizure in children admitted for severe bronchiolitis
Study Groups/Cohorts Children admitted in the PICU for severe bronchiolitis
Children admitted in the Pediatric Intensive Care Unit (PICU) for severe bronchiolitis between January 1st, 2010 and April 30th, 2018
Intervention: Other: Incidence, management and risk factors of seizure
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: July 15, 2019)
805
Original Actual Enrollment Same as current
Actual Study Completion Date May 1, 2019
Actual Primary Completion Date August 1, 2018   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • age < 90 days
  • hospitalization from January 1st, 2010 to April 30th, 2018 in the Pediatric Intensive Care Unit (PICU) of pediatric hospital in Lyon
  • with bronchiolitis (clinical diagnosis according to American Academy of Pediatrics)

Exclusion Criteria:

  • neurological history that may explain the occurrence of seizures
  • significant congenital heart disease
Sex/Gender
Sexes Eligible for Study: All
Ages up to 90 Days   (Child)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries France
Removed Location Countries  
 
Administrative Information
NCT Number NCT04022486
Other Study ID Numbers Bronchiolitis
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement Not Provided
Responsible Party Hospices Civils de Lyon
Study Sponsor Hospices Civils de Lyon
Collaborators Not Provided
Investigators
Principal Investigator: Florent BAUDIN, MD Hospices Civils de Lyon
PRS Account Hospices Civils de Lyon
Verification Date July 2019